ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "The Lens Newsletter: November 13th, 2024"
Episode Synopsis
In this week’s issue:
A retrospective study suggests that semaglutide is not associated with increased risk for non-arteritic anterior ischemic optic neuropathy (NAION).
Black patients were less likely to have conclusive genetic testing compared to White patients when screening for inherited retinal diseases.
Sodium-glucose co-transporter 2 inhibitors were shown to decrease risk of glaucoma compared to other antihyperglycemic agents.
A retrospective study suggests that semaglutide is not associated with increased risk for non-arteritic anterior ischemic optic neuropathy (NAION).
Black patients were less likely to have conclusive genetic testing compared to White patients when screening for inherited retinal diseases.
Sodium-glucose co-transporter 2 inhibitors were shown to decrease risk of glaucoma compared to other antihyperglycemic agents.
More episodes of the podcast The Lens Pod
The Lens Newsletter: December 17th, 2025
17/12/2025
The Lens Newsletter: December 10th, 2025
11/12/2025
The Lens Newsletter: December 3, 3025
03/12/2025
The Lens Newsletter: November 19, 2025
19/11/2025
The Lens Newsletter: November 12, 2025
12/11/2025
The Lens Newsletter: November 5, 2025
06/11/2025
The Lens Newsletter: October 29, 2025
29/10/2025
The Lens Newsletter: October 22, 2025
22/10/2025
The Lens Newsletter: October 15, 2025
15/10/2025
In God we trust